NCT05738694 2026-03-17Neoadjuvant of Axitinib Plus PD-1 to Improve Disease Free Survival of Patients With Renal Cell CarcinomaSun Yat-sen UniversityPhase 3 Recruiting298 enrolled
NCT06401330 2026-03-05A Study Using Risk Factors to Determine Treatment for Children With Favorable Histology Wilms Tumors (FHWT)Children's Oncology GroupPhase 3 Recruiting1,656 enrolled